Mutation-specific Codon Suppression for Aging and Longevity
VITARNA
Artan Bio has proposed a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. The solution involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation.
Owned by
0x452f3…8C80d
Contract:
0x7b66E…5F9C2
Description
Artan Bio has proposed a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. The solution involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation.Team
MT
Michael Torres
Research Lead
Organisation
Artan Bio, LLC
Experiment Cost
$91,300.00
Price of VITARNA
$0.557
Project Progress
All updates
All categories
Timeline
Loading...
Activity
Time | Type | $VITARNA | USD | ETH | From |
|---|---|---|---|---|---|